Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GSK | REGN | ARGX | ||
| Company | Gsk Plc ADR | Regeneron Pharmaceuticals | Argenx Se ADR | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 37.03 | 845.59 | 596.39 | ||
| High | 37.26 | 852.01 | 597.21 | ||
| Low | 36.94 | 826.76 | 582.44 | ||
| Last | 36.97 | 828.84 | 588.67 | ||
| Change | +0.09 | -14.76 | -6.91 | ||
| % Change | +0.24% | -1.75% | -1.16% | ||
| Volume | 3,994,500 | 743,600 | 265,700 | ||
| 20-Day Average Volume | 6,435,450 | 777,210 | 239,395 | ||
| Previous Close | 36.88 | 843.60 | 595.58 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 38.21 | 954.17 | 553.69 | ||
| 20-Day Raw Stochastic | 15.71% | 6.17% | 76.98% | ||
| 20-Day Relative Strength | 36.42% | 18.32% | 63.52% | ||
| Weighted Alpha | -1.34 | -10.01 | +38.47 | ||
| Today's Opinion | 88% Sell | 56% Sell | 100% Buy | ||
| Previous Opinion | 88% Sell | 56% Sell | 100% Buy | ||
| Last Month's Opinion | 8% Sell | 8% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.40% since 10/28/24 | -10.74% since 10/28/24 | +6.17% since 10/28/24 | ||
| Low | 36.07 on 10/31/24 | 815.99 on 10/31/24 | 545.55 on 10/30/24 | ||
| High | 38.26 on 10/29/24 | 935.86 on 10/30/24 | 610.73 on 11/01/24 | ||
| 1-Month | |||||
| %Chg | -4.77% since 10/04/24 | -18.17% since 10/04/24 | +11.08% since 10/04/24 | ||
| Low | 36.07 on 10/31/24 | 815.99 on 10/31/24 | 514.92 on 10/09/24 | ||
| High | 41.80 on 10/09/24 | 1,024.36 on 10/15/24 | 610.73 on 11/01/24 | ||
| 3-Month | |||||
| %Chg | -8.54% since 08/02/24 | -23.41% since 08/02/24 | +17.81% since 08/02/24 | ||
| Low | 36.07 on 10/31/24 | 815.99 on 10/31/24 | 475.65 on 08/05/24 | ||
| High | 44.67 on 08/27/24 | 1,211.20 on 08/27/24 | 610.73 on 11/01/24 | ||
| 6-Month | |||||
| %Chg | -15.01% since 05/03/24 | -13.39% since 05/03/24 | +51.64% since 05/03/24 | ||
| Low | 36.07 on 10/31/24 | 815.99 on 10/31/24 | 352.77 on 05/14/24 | ||
| High | 45.92 on 05/15/24 | 1,211.20 on 08/27/24 | 610.73 on 11/01/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 76,621,952 | 91,367,184 | 35,200,112 | ||
| Shares Outstanding, K | 2,072,544 | 110,235 | 59,796 | ||
| Annual Sales | 37,725,000,000 | 13,117,200,000 | 1,268,590,000 | ||
| Annual Net Income | 6,129,940,000 | 3,953,600,000 | -295,050,000 | ||
| Last Quarter Sales | 10,420,410,000 | 3,720,700,000 | 588,880,000 | ||
| Last Quarter Net Income | -75,430,000 | 1,340,600,000 | 91,410,000 | ||
| 60-Month Beta | 0.66 | 0.15 | 0.61 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.27 on 10/30/24 | 12.46 on 10/31/24 | 1.39 on 10/31/24 | ||
| Latest Earnings Date | 10/30/24 | 10/31/24 | 10/31/24 | ||
| Most Recent Dividend | 0.385 on 08/16/24 | N/A | N/A | ||
| Next Ex-Dividends Date | 11/15/24 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 8.84 | 21.10 | 0.00 | ||